# NEUROSENSE THERAPEUTICS LTD (NRSNW)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/NRSNW/

- Reporting holders: 3
- Reported value: $10.4K
- Shares held by institutions: 164,650 of 32,557,174 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Empery Asset Management, LP](https://holderbook.com/funds/1469336-empery-asset-management-lp/) | $6.3K | 100,402 | 0.0% | 7 |
| [Clear Street Group Inc.](https://holderbook.com/funds/1881567-clear-street-group-inc/) | $4.0K | 63,085 | 0.0% | 4 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $73 | 1,163 | 0.0% | 9 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 3 | $10.4K |
| Q1 2026 | 3 | $32.8K |
| Q4 2025 | 3 | $56.7K |
| Q3 2025 | 2 | $24.6K |
| Q2 2025 | 2 | $41.3K |
| Q1 2025 | 3 | $16.1K |
| Q4 2024 | 4 | $43.9K |
| Q3 2024 | 4 | $17.1K |
| Q2 2024 | 4 | $25.0K |
| Q1 2024 | 4 | $98.9K |
| Q4 2023 | 3 | $18.3K |
| Q3 2023 | 6 | $50.3K |